X-Received: by 2002:a5d:638b:0:b0:218:54a2:71d0 with SMTP id p11-20020a5d638b000000b0021854a271d0mr2226347wru.36.1655340493425;
Wed, 15 Jun 2022 17:48:13 -0700 (PDT)
X-Received: by 2002:a81:5758:0:b0:317:5feb:9d76 with SMTP id
l85-20020a815758000000b003175feb9d76mr2800961ywb.240.1655340492962; Wed, 15
Jun 2022 17:48:12 -0700 (PDT)
Path: i2pn2.org!i2pn.org!usenet.goja.nl.eu.org!3.eu.feeder.erje.net!feeder.erje.net!proxad.net!feeder1-2.proxad.net!209.85.128.88.MISMATCH!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: uk.comp.homebuilt
Date: Wed, 15 Jun 2022 17:48:12 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=104.223.100.138; posting-account=hkCnjwoAAAD931FDYXyewH5MrRYaKfqN
NNTP-Posting-Host: 104.223.100.138
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <f6344f97-aa94-432d-82f7-00000adfcef7n@googlegroups.com>
Subject: (PDF) New Psychoactive Substances - Pharmacology, Clinical, by Maurer
From: hesterho...@gmail.com (Hester Holt)
Injection-Date: Thu, 16 Jun 2022 00:48:13 +0000
Content-Type: text/plain; charset="UTF-8"